Does Testosterone Cream Cause Hair Loss?

Testosterone cream can accelerate hair loss, but only in people whose hair follicles are genetically sensitive to androgens. The mechanism involves the conversion of testosterone into dihydrotestosterone (DHT), and transdermal formulations like creams and gels raise DHT levels more dramatically than other testosterone delivery methods. Whether that elevated DHT actually thins your hair depends far less on how much DHT circulates in your blood than on what your follicles do with it once it arrives.

How Testosterone Leads to Hair Thinning

Testosterone itself is not the molecule that shrinks hair follicles. An enzyme called 5-alpha reductase, particularly the type 2 form, converts testosterone into DHT inside the hair follicle. DHT then binds to androgen receptors in susceptible follicles, gradually miniaturizing them over repeated hair cycles until they produce only fine, nearly invisible hairs or stop producing hair altogether.¹ This process is what dermatologists call androgenetic alopecia, and it accounts for the vast majority of patterned hair loss in both men and women.

Not all follicles are equally vulnerable. Researchers have found that frontal scalp follicles carry higher levels of both 5-alpha reductase and androgen receptors than follicles at the back of the head. That difference explains why pattern hair loss recedes from the temples and crown first while the occipital region stays thick. The back of the head also has higher levels of aromatase, an enzyme that converts testosterone into estrogen rather than DHT, giving those follicles a kind of built-in protection.²

Why Creams and Gels Raise DHT More Than Injections

This is where the route of delivery matters and where testosterone cream stands out. When testosterone is absorbed through the skin, it passes through a layer rich in 5-alpha reductase before ever reaching general circulation. The skin itself converts a significant portion of that testosterone into DHT on first pass. A systematic review and meta-analysis of testosterone replacement studies found that transdermal formulations raised serum DHT about five and a half times above baseline, compared to roughly a two-fold increase with intramuscular injections.³ That is a substantial difference. If you are using a cream or gel and are genetically predisposed to pattern hair loss, you are getting a larger DHT load than someone on injections with the same testosterone level.

Application site adds another layer. When testosterone cream is applied to scrotal skin, absorption is especially rapid, with serum testosterone peaking within about two to three hours and DHT following shortly after, reaching around 1.2 ng/mL by about five hours.⁴ Scrotal application is sometimes used deliberately to achieve higher DHT levels for specific clinical goals, but it also means a bigger androgenic stimulus hitting the scalp follicles indirectly through the bloodstream.

Genetics Matter More Than Blood Levels

Here is where the picture gets less straightforward than “more DHT equals more hair loss.” A study examining the relationship between serum DHT levels and the severity of androgenetic alopecia found that increased DHT concentrations in the blood did not correlate with how advanced the balding was. The researchers concluded that the genetically determined sensitivity of individual follicles to DHT, and the way each follicle reacts to whatever androgen reaches it, matters more than the absolute amount of hormone circulating.⁵

That finding explains a common observation: some men on high-dose testosterone maintain a full head of hair while others start thinning on modest replacement doses. Family history remains the strongest predictor. If your father and maternal grandfather lost hair in a classic pattern, your follicles are more likely to be sensitive to DHT regardless of whether your testosterone comes from a cream, a patch, an injection, or your own production. What testosterone cream does is raise the DHT signal, and in someone whose follicles are already listening, that louder signal can speed up a process that was going to happen eventually.

Population-level data bears this out. In one study tracking men who used anabolic-androgenic steroids (at doses well above standard replacement), only about 2% reported hair loss early in the cycle. After roughly three and a half months, that figure rose to 12%, while 5% actually reported increased scalp hair growth.⁶ The takeaway is that even with supraphysiological testosterone doses, the majority did not experience noticeable hair loss, underscoring the role of individual genetic vulnerability.

Higher Testosterone Levels and Balding in Population Studies

While follicle sensitivity drives the pattern, testosterone and DHT levels are not completely irrelevant. In a study comparing men with vertex baldness to men without hair loss, the balding group had significantly higher total and free testosterone levels on average. A separate study of 22 people with hair loss and 11 controls found that the hair loss group had testosterone levels averaging about 4.36 ng/mL compared to roughly 3.05 ng/mL in controls.⁶ These are associations rather than proof that higher testosterone directly caused the loss, but they suggest that in populations already susceptible, higher circulating androgens correlate with more advanced thinning. That correlation is relevant if you are raising your androgens externally with a cream.

Evidence from Transgender Men on Testosterone Therapy

Some of the clearest data on what happens to hair when testosterone is introduced to a body that previously had low levels comes from studies of transgender men starting masculinizing hormone therapy. In one longitudinal study, only one trans man developed mild frontotemporal hair loss during the first year of testosterone treatment. But after long-term therapy, about a third had mild frontotemporal hair loss and another third had moderate to severe androgenetic alopecia.⁷

That timeline matters. Hair loss from testosterone therapy rarely shows up overnight. In another study of trans men who developed male-pattern hair loss, the mean onset was about three and a quarter years after starting androgenic treatment, and 70% of those affected had a family history of hair loss.⁸ These findings mirror what happens in cisgender men going through puberty, with hair loss appearing years after androgen levels rise, and family history remaining a strong predictor of who is affected.

The transgender men data is especially useful because it shows the effect of introducing testosterone into a system that was not previously androgenized at male-typical levels. The hair loss rates after long-term therapy look remarkably similar to what you see in cisgender men in general, suggesting that the testosterone dose and duration, combined with inherited follicle sensitivity, produce the same pattern regardless of whether the testosterone comes from the body’s own production or from a prescription.

Skin Side Effects Across Different Formulations

Hair loss is not the only dermatological concern with testosterone replacement. A scoping review of skin-related side effects across testosterone formulations found that acne was the most common issue, affecting up to about 9% of participants depending on the delivery method, with injectable formulations generally causing higher rates than topical or oral forms. Abnormal hair growth (on the body, not the scalp) affected up to about 5% of users, and skin reactions like itching and rashes were also reported with topical products specifically.⁹

The review did not find that one formulation caused dramatically more scalp hair loss than another, though the DHT data described earlier suggests creams and gels should theoretically carry a higher risk. The practical difficulty is that hair loss develops slowly and often goes unreported in clinical trials that last only months. Many trials simply do not track it carefully enough to catch what amounts to a gradual thinning over years.

Can You Use Testosterone Cream and Prevent Hair Loss?

Finasteride, the most widely prescribed drug for pattern hair loss, works by blocking the type 2 5-alpha reductase enzyme that converts testosterone to DHT. Several studies have looked at whether it can be used alongside testosterone replacement without undermining testosterone’s benefits. In a randomized trial of older men with low testosterone, combining testosterone with finasteride still produced significant gains in muscle strength, lean body mass, and bone density over 12 months. Finasteride completely prevented the prostate enlargement that testosterone alone caused but did not interfere with the musculoskeletal or body composition improvements.¹⁰

A longer trial spanning 36 months confirmed the same pattern: testosterone improved physical performance and grip strength whether given alone or with finasteride, and the researchers noted that high serum DHT levels were not essential for these benefits.¹¹ This is good news for men who want both testosterone replacement and hair preservation. Finasteride blocks the enzyme driving hair loss without stripping away the muscle, bone, and energy effects most people seek from testosterone therapy.

Minoxidil is another option, and it works through a completely different mechanism, improving blood flow to follicles and extending the growth phase of the hair cycle. A randomized, placebo-controlled trial in transgender people receiving testosterone therapy found that sublingual minoxidil improved midfrontal hair counts by about 16 hairs per square centimeter over 24 weeks compared to placebo. Gains at the vertex took longer to appear but were substantial by 48 weeks, with an increase of nearly 38 hairs per square centimeter.¹² For people who want to avoid finasteride, whether because of its side effect profile or because they need high DHT for other clinical reasons, minoxidil represents a viable alternative that does not interfere with androgen metabolism.

Switching Delivery Methods as a Strategy

Given that transdermal testosterone raises DHT about five and a half times above baseline while injections raise it about twofold, some clinicians suggest switching from a cream or gel to injections if hair loss is a concern.³ The logic is straightforward: lower DHT means less androgenic signaling at the follicle. This approach is not guaranteed to stop or reverse thinning, especially in someone with strong genetic susceptibility, but it reduces one variable in the equation. It is worth discussing with a prescribing doctor, since changing formulations affects not just DHT but also the testosterone level profile throughout the day, and some people have strong preferences for convenience, absorption consistency, or injection avoidance.

Oral testosterone formulations represent another option. The scoping review of dermatological side effects found that oral forms had the lowest incidence of acne, though it did not break out scalp hair loss data by formulation in a way that allows a clean comparison.⁹ Newer oral testosterone undecanoate products bypass the liver’s first-pass metabolism through lymphatic absorption, which may produce a different DHT profile, though direct head-to-head comparisons with creams specifically for hair outcomes are lacking.

Secondary Exposure and Unintended Hair Effects in Others

An underappreciated risk of testosterone cream is transfer to other people through skin contact. Case reports and clinical trials have documented that testosterone gel can transfer from a treated person to a partner, child, or pet through touching. This can cause virilization in women and children, including signs like increased body hair, voice changes, and acne.¹³ For a female partner, prolonged inadvertent exposure could theoretically trigger the same follicle-level androgenization that leads to hair thinning in predisposed individuals.

Researchers have confirmed that testosterone gel application without protective measures like covering the site or washing hands can cause clinically significant contamination in household members.¹⁴ Women’s frontal follicles have about 40% fewer androgen receptors than men’s, which provides some buffer, but it is not complete protection.² If you use testosterone cream, keeping the application site covered and washing your hands thoroughly afterward is important not just for your own health but for the people around you.

What Men Who Are Already Thinning Should Know

If you are already noticing hair loss and are considering testosterone cream, or if you have been on it and your hair seems to be thinning faster, a few practical points are worth keeping in mind. First, the hair loss you are experiencing may have nothing to do with the cream. Androgenetic alopecia is extremely common, affects most men eventually, and progresses on its own. Second, if the timing lines up suspiciously with starting testosterone, the cream’s DHT-boosting effect is a plausible accelerator, and switching formulations or adding finasteride are evidence-backed responses. Third, give any intervention time to work. Hair follicles cycle over months, and neither the damage nor the recovery happens quickly. The transgender men studies showed onset averaging over three years; improvements from treatments like minoxidil took six months to a year to fully emerge.

One counterintuitive finding that sometimes confuses people: men who are genetically born without functional type 2 5-alpha reductase do not develop male-pattern baldness. This was one of the original clues that DHT, not testosterone itself, drives pattern hair loss. Finasteride mimics that protection pharmacologically by blocking the same enzyme. The fact that these men also have certain developmental differences underscores that DHT is not a throwaway hormone, but for the specific purpose of keeping scalp hair, blocking its production at the follicle is effective and, based on the trial data combining finasteride with testosterone, does not sacrifice the main goals of testosterone therapy.

1
Dermatology. Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
2
PubMed. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia
3
PubMed Central. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
4
PubMed Central. Pharmacokinetics of testosterone cream applied to scrotal skin
5
PubMed Central. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
6
PubMed Central. Hair loss in athletic testosterone use in males: a narrative review
7
The Journal of Sexual Medicine. Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
8
Clinical and Experimental Dermatology. Therapeutic experience with oral finasteride for androgenetic alopecia in female‐to‐male transgender patients
9
Sexual Medicine Reviews. Dermatological adverse effects of testosterone replacement therapy: a scoping review of the literature
10
PubMed Central. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial
11
The Journal of Clinical Endocrinology & Metabolism. Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
12
PubMed. Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial
13
PubMed. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies
14
PubMed. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation